OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization
Ali Akbari, Fereshteh Nazari‐Khanamiri, Mahdi Ahmadi, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 66-66
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application
Qian Yang, Shisheng Li, Haibo Ou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 48

Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20

Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy
Vinith Johnson, Sunil Vasu, Uday Kumar Sukumar, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2838-2838
Open Access | Times Cited: 39

Research Advances of Engineered Exosomes as Drug Delivery Carrier
Lianghui Huang, Enguang Wu, Jiawei Liao, et al.
ACS Omega (2023) Vol. 8, Iss. 46, pp. 43374-43387
Open Access | Times Cited: 36

Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look
Zahra Abbasi‐Malati, Seyed Ghader Azizi, Soheil Zamen Milani, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9

EXOTLR1/2-STING: A Dual-Mechanism Stimulator of Interferon Genes Activator for Cancer Immunotherapy
Tianyang Wang, Hong-Guo Hu, Lang Zhao, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1

Recent advances and future prospects of engineered exosomes as advanced drug and gene delivery systems
Waleed Y. Rizg, Majed Alghamdi, Sherif El Saadany, et al.
Journal of Drug Delivery Science and Technology (2025) Vol. 106, pp. 106696-106696
Closed Access | Times Cited: 1

Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics
Nobendu Mukerjee, Swastika Maitra, Mandeep Kaur, et al.
Chemical Engineering Journal (2025), pp. 160915-160915
Closed Access | Times Cited: 1

Exosome surface modification and functionalization: a narrative review of emerging technologies and their application potential in precision medicine
Ta‐Hsiang Chao, Jingjing Zhao, Ruifang Gao, et al.
Advanced technology in neuroscience . (2025) Vol. 2, Iss. 1, pp. 27-33
Closed Access | Times Cited: 1

The potential application of encapsulated exosomes: A new approach to increase exosomes therapeutic efficacy
Ali Hazrati, Zahra Mirsanei, N. Heidari, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114615-114615
Open Access | Times Cited: 22

Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance
Chen Ming‐Kun, Chen Zi‐Xian, Cai Mao‐Ping, et al.
Cancer Communications (2023) Vol. 44, Iss. 2, pp. 205-225
Open Access | Times Cited: 18

Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
Philemon Ubanako, Sheefa Mirza, Paul Ruff, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 7

Exosomes: Diagnostic and Therapeutic Implications in Cancer
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1465-1465
Open Access | Times Cited: 16

Functionalized exosomes for cancer therapy
Subham Preetam, R Rath, Sofia Sharief Khan, et al.
Elsevier eBooks (2024), pp. 167-180
Closed Access | Times Cited: 5

Exosomes as a drug delivery tool for cancer therapy: a new era for existing drugs and oncolytic viruses
Yoshihiko Kakiuchi, Shinji Kuroda, Nobuhiko Kanaya, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 807-816
Closed Access | Times Cited: 11

Lung cancer cell-derived exosomes: progress on pivotal role and its application in diagnostic and therapeutic potential
Aimi Syamima Abdul Manap, Faith Malambo Ngwenya, Meilarshny Kalai Selvan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4

The latest applications of exosome-mediated drug delivery in anticancer therapies
Zhiwei Wen, Wei Zhang, Wei Wu
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114500-114500
Closed Access

Extracellular Vesicle-based Delivery of Paclitaxel to Lung Cancer Cells: Uptake, Anticancer Effects, Autophagy and Mitophagy Pathways
Shabnam Pirnezhad Talatapeh, Jafar Rezaie, Vahid Nejati
Archives of Medical Research (2025) Vol. 56, Iss. 4, pp. 103194-103194
Closed Access

Exosome-based platforms for treatment of multiple sclerosis
Aidin Mohammadi Zonouz, Mahboobeh Ghasemzadeh Rahbardar, Mona Alibolandi
Brain Research Bulletin (2025) Vol. 222, pp. 111256-111256
Open Access

Delivering RNA through exosomes for cancer therapy
Tianming Zhao, Jinping Wang
Journal of Nanoparticle Research (2025) Vol. 27, Iss. 4
Closed Access

Bispecific Antibodies, Nanobodies and Extracellular Vesicles: Present and Future to Cancer Target Therapy
Asier Lizama-Muñoz, Julio Plaza‐Díaz
Biomolecules (2025) Vol. 15, Iss. 5, pp. 639-639
Open Access

Recent advances in targeted therapy on cancers by nanoparticles encapsulated in exosomes: a comprehensive review
Wajida Ataallah Khidr, Karar H. Alfarttoosi, Waam Mohammed Taher, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 107033-107033
Closed Access

Page 1 - Next Page

Scroll to top